Sale!

Menorrhagia Screen Test

Original price was: $238.Current price is: $176.

-26%

The Menorrhagia Screen Test is a comprehensive diagnostic panel designed to evaluate the underlying causes of excessive menstrual bleeding. This specialized test measures key coagulation factors including Prothrombin Time, APTT, Factor VIII Functional, and Factor IX levels to identify potential bleeding disorders. Women experiencing heavy, prolonged periods that interfere with daily activities should consider this test. The screening provides crucial insights into coagulation abnormalities that may contribute to menorrhagia, enabling targeted treatment approaches. Results are typically available the next day with proper sample collection. The test costs $176 USD and offers significant savings from the regular $238 USD price. Early detection through this screening can prevent complications and improve quality of life.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Menorrhagia Screen Test: Comprehensive Heavy Menstrual Bleeding Diagnosis

Understanding Menorrhagia and Its Diagnostic Importance

Menorrhagia, clinically defined as excessive or prolonged menstrual bleeding, affects millions of women worldwide and can significantly impact quality of life. The Menorrhagia Screen Test represents a crucial diagnostic advancement in identifying the underlying causes of abnormal uterine bleeding. This comprehensive panel evaluates coagulation pathways and clotting factors that play essential roles in normal menstrual cycle regulation and hemostasis.

Heavy menstrual bleeding isn’t just an inconvenience—it can indicate serious underlying health conditions that require medical attention. The importance of this screening lies in its ability to differentiate between various potential causes, from coagulation disorders to hormonal imbalances, enabling healthcare providers to develop targeted treatment strategies that address the root cause rather than just managing symptoms.

What the Menorrhagia Screen Test Measures and Detects

This specialized diagnostic panel utilizes advanced electromechanical and photo-optical clot detection methods to assess multiple components of the coagulation cascade:

Primary Test Components:

  • Prothrombin Time (PT): Evaluates the extrinsic and common pathways of coagulation, measuring factors I, II, V, VII, and X
  • Activated Partial Thromboplastin Time (APTT): Assesses the intrinsic and common coagulation pathways, screening for deficiencies in factors VIII, IX, XI, XII, and others
  • Factor VIII Functional Assay: Specifically measures the activity level of coagulation factor VIII, crucial for proper clot formation
  • Factor IX Assessment: Evaluates the functionality of Christmas factor, essential for intrinsic pathway coagulation

These comprehensive measurements help identify coagulation abnormalities that may contribute to excessive menstrual bleeding, including von Willebrand disease, hemophilia carriers, and other inherited or acquired bleeding disorders.

Who Should Consider the Menorrhagia Screen Test

This diagnostic screening is particularly recommended for women experiencing the following symptoms:

  • Menstrual periods lasting longer than 7 days
  • Needing to change sanitary protection every 1-2 hours
  • Passing large blood clots during menstruation
  • Experiencing symptoms of anemia, including fatigue, weakness, or shortness of breath
  • Heavy bleeding that interferes with daily activities and work
  • Family history of bleeding disorders or coagulation abnormalities
  • Previous unexplained bruising or prolonged bleeding from minor cuts
  • Women planning surgical procedures who have history of heavy periods

Significant Benefits of Menorrhagia Screening

Undergoing the Menorrhagia Screen Test offers numerous advantages for women’s health management:

Early Detection and Intervention

Identifying coagulation disorders early allows for timely intervention and appropriate management strategies, potentially preventing complications such as severe anemia, iron deficiency, and the need for emergency medical care.

Personalized Treatment Planning

Accurate diagnosis enables healthcare providers to develop targeted treatment plans, whether through hormonal therapies, antifibrinolytic medications, or specific coagulation factor replacements based on individual test results.

Improved Quality of Life

Proper diagnosis and management can significantly reduce the physical and emotional burden of heavy menstrual bleeding, restoring normal daily function and reducing anxiety associated with unpredictable bleeding episodes.

Comprehensive Health Assessment

The test provides valuable insights into overall coagulation health, which can have implications beyond menstrual bleeding, including surgical planning and understanding bleeding risks in other contexts.

Understanding Your Test Results

Interpreting Menorrhagia Screen Test results requires professional medical expertise, but here’s general guidance on what different findings might indicate:

Normal Results

Normal coagulation parameters suggest that bleeding disorders are unlikely the primary cause of menorrhagia, directing further investigation toward hormonal imbalances, structural abnormalities, or other gynecological conditions.

Abnormal Coagulation Parameters

Prolonged PT or APTT times may indicate deficiencies in specific coagulation factors. Elevated results could point toward conditions like von Willebrand disease, hemophilia carrier status, or acquired coagulation disorders requiring specialized hematological consultation.

Factor-Specific Abnormalities

Isolated factor deficiencies provide precise diagnostic information, enabling targeted replacement therapies or specific management approaches tailored to the identified coagulation defect.

Important: Always discuss your results with a qualified healthcare provider who can provide personalized interpretation and treatment recommendations based on your complete medical history and clinical presentation.

Test Pricing and Availability

Test Component Discount Price Regular Price
Menorrhagia Screen Test $176 USD $238 USD

Nationwide Availability and Convenient Testing

We have diagnostic branches conveniently located across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards regardless of location.

Sample Collection and Turnaround

Turnaround Time: Sample collected Thursday by 11 AM; Report available next day
Sample Type: 6 mL whole blood in 2 Blue Top (Sodium Citrate) tubes

Pre-Test Instructions

  • Overnight fasting is preferred for optimal results
  • Complete coagulation Requisition form (Form 15) is mandatory
  • Consult your physician about temporarily discontinuing Heparin (1 day) and Oral Anticoagulants (7 days) prior to testing, as these medications may affect results
  • Any medication adjustments should only be made with your treating physician’s approval

Take Control of Your Reproductive Health Today

Don’t let heavy menstrual bleeding control your life. The Menorrhagia Screen Test provides the comprehensive diagnostic information needed to understand the underlying causes of excessive bleeding and develop effective treatment strategies. Our experienced team and advanced testing methodologies ensure accurate, reliable results you can trust.

Ready to take the next step toward better health? Book your Menorrhagia Screen Test today!
Call or WhatsApp: +1(267) 388-9828

Our compassionate healthcare professionals are available to answer your questions, schedule your appointment, and guide you through the testing process. Take advantage of our special discounted price of $176 USD and invest in understanding your health better.